Drawing for SPEYWOOD UNITS

USPTO serial 86685003

SPEYWOOD UNITS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
HARDY LUDLOW, TARAH KIM
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SPEYWOOD UNITS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William S. Frommer

WILLIAM S. FROMMER FROMMER LAWRENCE & HAUG LLP745 5TH AVENEW YORK, NY 10151-0099UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Non-medicated cosmetic preparations for the treatment of frown lines and other wrinkles, in particular facial wrinkles; non-medicated cosmetic preparations for the treatment of interciliary furrows, glabellar lines, facial wrinkles, hyperfunctional facial lines, human skin wrinkles and of asymmetries, imbalances and defects of the human skin; non-medicated cosmetic preparations for skin renewal and the treatment of baldness; non-medicated cosmetic preparations comprising botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivativesACTIVE—
005Pharmaceutical preparations for the treatment of muscle disorders, neurological disorders, orthopaedic disorders, age-related disorders, ophthalmological disorders; pharmaceutical preparations for the treatment of pain, muscle spasms, blepharospasm and/or hemifacial spasm; pharmaceutical preparations for the treatment of cerebral palsy, dystonia, torticollis, articular pathologies, acne, headache, migraine, hyperhidrosis, myofascial pain, hyperfunctional facial lines; pharmaceutical preparations for use in cosmetic surgery; pharmaceutical preparations for use in cosmetic surgery; pharmaceutical preparations for the treatment of frown lines and/or other facial wrinkles; pharmaceutical preparations for the treatment of interciliary furrows, glabellar lines, facial wrinkles, hyperfunctional facial lines, human skin wrinkles and asymmetries and defects of the human skin; pharmaceutical preparations for the treatment of scars and psoriasis; pharmaceutical preparations comprising botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and other botulinum toxin derivatives; injectable cosmetic preparationsACTIVE—
010Medical kits containing fluid injection needles and pharmaceuticals, namely, preparations for the treatment of muscle disorders, neurological disorders, orthopaedic disorders, age-related disorders, ophthalmological disorders, pain, muscle spasms, blepharospasm and/or hemifacial spasm, cerebral palsy, dystonia, torticollis, articular pathologies, acne, headache, migraine, hyperhidrosis, myofascial pain, hyperfunctional facial lines; and transportable battery-operated electromyogram machines and amplifiers for sameACTIVE—
042Pharmaceutical research services and development of pharmaceutical preparations and medicines; pharmaceutical research and development; research and development, and consultation related to research and development, all in the field of medicine, pharmacy, beauty, lifestyles, cosmetics and healthcareACTIVE—
044Medical services; hygienic and beauty care for human beings; non-invasive cosmetic medical proceduresACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 20, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 20, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 18, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 17, 2018EX5GSOU EXTENSION 5 GRANTED—
Aug 17, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 9, 2018EXT5SOU EXTENSION 5 FILED—
Aug 9, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 23, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 21, 2018EX4GSOU EXTENSION 4 GRANTED—
Feb 21, 2018EXT4SOU EXTENSION 4 FILED—
Feb 21, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 5, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 3, 2017EX3GSOU EXTENSION 3 GRANTED—
Oct 3, 2017EXT3SOU EXTENSION 3 FILED—
Oct 3, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 28, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 24, 2017EX2GSOU EXTENSION 2 GRANTED—
Mar 24, 2017EXT2SOU EXTENSION 2 FILED—
Mar 24, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 6, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 4, 2016EX1GSOU EXTENSION 1 GRANTED—
Oct 4, 2016EXT1SOU EXTENSION 1 FILED—
Oct 4, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 19, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 23, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 23, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 3, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 21, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 12, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 12, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jan 12, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 12, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 12, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 12, 2016ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jan 5, 2016PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Dec 22, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 18, 2015ALIEASSIGNED TO LIE—
Dec 14, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 14, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 14, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 10, 2015ALIEASSIGNED TO LIE—
Nov 24, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 22, 2015GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 22, 2015GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 22, 2015CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Oct 16, 2015DOCKASSIGNED TO EXAMINER—
Jul 11, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Jul 10, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 10, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance